Alloderm
Device Plastic Surgery
General payments
$51,332,611
Research payments
$115,410
Through program year 2025, $51,332,611 in general payments and $115,410 in research payments were reported against Alloderm (Plastic Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $7,588,614 | 3,782 |
| 2024 | General | $7,401,138 | 3,519 |
| 2023 | General | $11,845,865 | 3,130 |
| 2022 | General | $22,303,451 | 106 |
| 2022 | Research | $27,170 | 1 |
| 2021 | General | $707 | 33 |
| 2021 | Research | $2,128 | 2 |
| 2020 | General | $211,440 | 111 |
| 2020 | Research | $30,000 | 1 |
| 2019 | General | $1,981,395 | 4,595 |
| 2019 | Research | $56,112 | 9 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
15,276 general · 13 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.